A Systematic Review of the Use of Janus Kinase Inhibitors in Large Vessel Vasculitis.
Chay Timmie, Patel Tirath, Dumaru Nabina, +4 more·Cureus
Janus kinase inhibitors (JAKi) are emerging agents in the treatment of rheumatological diseases. Their role in rheumatoid arthritis and spondyloarthropathies has been established. The treatment of Takayasu Arteritis (TAK) and Giant Cell Arteritis (GCA) is large vessel vasculitis requiring long courses of glucocorticoid…